Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study.

Adolescent Adult Aged Aged, 80 and over Bayes Theorem Case-Control Studies Female Genotype Humans Infectious Mononucleosis / genetics Lymphoma, Non-Hodgkin / genetics Male Middle Aged Risk Factors Self Report Young Adult
Gene–environment interaction Infectious mononucleosis Interleukin-1beta (IL1B) Interleukin-6 (IL6) Non-Hodgkin lymphoma T-cell lymphoma

Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
05 2020
Historique:
received: 19 06 2019
accepted: 03 01 2020
pubmed: 4 3 2020
medline: 19 8 2020
entrez: 4 3 2020
Statut: ppublish

Résumé

We explored the interaction between non-Hodgkin lymphoma (NHL), infectious mononucleosis (IM) history, and immune-related genotypes in a pooled case-control analysis. A total of 7,926 NHL patients and 10,018 controls from 12 case-control studies were included. Studies were conducted during various time periods between 1988 and 2008, and participants were 17-96 years of age at the time of ascertainment/recruitment. Self-reported IM history and immune response genotypes were provided by the InterLymph Data Coordinating Center at Mayo Clinic. Odds ratios (OR) were estimated using multivariate logistic regression, and interactions were estimated using the empirical Bayes method. P There was evidence of an interaction effect between IM history and two variants on T-cell lymphoma (TCL) risk: rs1143627 in interleukin-1B (IL1B) (p Genetic risk variants in IL1B and IL6 may affect the association between IM and TCL, possibly by influencing T-cell activation, growth, and differentiation in the presence of IM, thereby decreasing risk of immune cell proliferation.

Identifiants

DOI: 10.1007/s10552-020-01266-4 PMID: 32124188 PMC: PMC7534692
pubmed: 32124188
doi: 10.1007/s10552-020-01266-4
pii: 10.1007/s10552-020-01266-4
pmc: PMC7534692
mid: NIHMS1623166
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-462

Subventions

Organisme : NCI NIH HHS
ID : N01-CN-75014-20
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201000140C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201000035C
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA118948
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NCI NIH HHS
ID : R01-CA-186646
Pays : United States
Organisme : NCI NIH HHS
ID : R21-CA-155951
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA155951
Pays : United States
Organisme : NCI NIH HHS
ID : U54-CA-118948
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201000035I
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201000034C
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA087014
Pays : United States
Organisme : NCI NIH HHS
ID : R01-CA-045614
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA013148
Pays : United States
Organisme : NCI NIH HHS
ID : R01-CA-104682
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA186646
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA154643
Pays : United States
Organisme : NCI NIH HHS
ID : P30-CA-13148
Pays : United States
Organisme : NCI NIH HHS
ID : P30-CA-014089
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA104682
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U58 DP003862
Pays : United States
Organisme : NCI NIH HHS
ID : R01-CA-154643
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA045614
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12014/3
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Blood. 2007 Dec 15;110(13):4455-63
pubmed: 17827388
PLoS Pathog. 2015 Mar 27;11(3):e1004746
pubmed: 25816224
Genet Epidemiol. 2008 Nov;32(7):615-26
pubmed: 18473390
Br J Haematol. 1994 Oct;88(2):392-4
pubmed: 7803287
Blood. 2007 Jul 15;110(2):695-708
pubmed: 17389762
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):401-4
pubmed: 17337646
Nat Rev Rheumatol. 2016 Jan;12(1):14-24
pubmed: 26656658
Blood. 2010 Jun 10;115(23):4820-3
pubmed: 20385791
Transfus Med Hemother. 2013 Oct;40(5):336-43
pubmed: 24273487
Br J Haematol. 2011 Mar;152(6):721-6
pubmed: 21250972
J Clin Virol. 2012 Nov;55(3):226-32
pubmed: 22841751
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):405-8
pubmed: 17337643
Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1415-21
pubmed: 15342441
Cancer Causes Control. 2003 Sep;14(7):687-94
pubmed: 14575367
Clin Cancer Res. 2012 Sep 15;18(18):5051-60
pubmed: 22850569
Blood. 2008 Apr 15;111(8):4029-38
pubmed: 18263783
Clin Transl Immunology. 2015 Feb 27;4(2):e33
pubmed: 25774295
PLoS Genet. 2011 Apr;7(4):e1001378
pubmed: 21533074
Nat Genet. 2010 Aug;42(8):661-4
pubmed: 20639881
Clin Infect Dis. 2014 Jun;58(12):1684-9
pubmed: 24696238
Ann Oncol. 1990;1(1):45-50
pubmed: 1706610
J Immunol. 1988 Apr 15;140(8):2639-44
pubmed: 2965728
Int J Cancer. 2007 Dec 15;121(12):2767-75
pubmed: 17722095
Am J Epidemiol. 1999 Aug 15;150(4):375-89
pubmed: 10453814
Epidemiol Infect. 2012 Nov;140(11):2089-95
pubmed: 22152594
Nat Commun. 2017 Sep 19;8(1):599
pubmed: 28928442
Int J Cancer. 2012 Nov 15;131(10):2342-8
pubmed: 22266776
Proc Natl Acad Sci U S A. 1988 Dec;85(24):9699-703
pubmed: 3264404
J Biol Chem. 2000 Jun 16;275(24):18138-44
pubmed: 10747905
Proc Natl Acad Sci U S A. 1985 Dec;82(23):8153-7
pubmed: 3877937
J Natl Cancer Inst. 2005 Feb 2;97(3):199-209
pubmed: 15687363
Ann Oncol. 2014 Nov;25(11):2211-2217
pubmed: 25193992
Br J Haematol. 2009 Jun;146(1):91-4
pubmed: 19438470
Bioinformatics. 2008 Dec 15;24(24):2938-9
pubmed: 18974171
J Infect Dis. 1979 May;139(5):553-8
pubmed: 220340
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):66-75
pubmed: 25174027
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1799-806
pubmed: 22911334
Int J Cancer. 2006 Aug 15;119(4):901-8
pubmed: 16557575
Am J Epidemiol. 2003 Aug 15;158(4):316-27
pubmed: 12915497
Int J Mol Epidemiol Genet. 2011;2(2):95-113
pubmed: 21686124
Int J Cancer. 2004 Dec 10;112(5):865-71
pubmed: 15386383
Lancet Oncol. 2006 Jan;7(1):27-38
pubmed: 16389181
J Clin Invest. 2007 Oct;117(10):3042-8
pubmed: 17909631
Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1061-70
pubmed: 25962811
Front Immunol. 2019 Sep 18;10:2193
pubmed: 31620125
N Engl J Med. 2010 May 27;362(21):1993-2000
pubmed: 20505178
Blood. 2008 Dec 15;112(13):5150-60
pubmed: 18796628
Cancer Causes Control. 2007 Oct;18(8):821-31
pubmed: 17588155
N Engl J Med. 2004 Mar 25;350(13):1328-37
pubmed: 15044644
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14
pubmed: 25174022
Rev Med Virol. 2015 Mar;25(2):71-84
pubmed: 25430668
Int Immunol. 2006 May;18(5):701-12
pubmed: 16569679
J Cancer Res Clin Oncol. 2009 Aug;135(8):1099-107
pubmed: 19205736
Am J Hum Genet. 2007 Dec;81(6):1158-68
pubmed: 17966093
Nat Med. 1996 Aug;2(8):906-11
pubmed: 8705861
N Engl J Med. 1994 May 5;330(18):1267-71
pubmed: 8145781
Tissue Antigens. 2012 Apr;79(4):279-86
pubmed: 22296171
Am J Epidemiol. 2010 Feb 1;171(3):267-76
pubmed: 20047977
Blood. 2010 Nov 18;116(20):e90-8
pubmed: 20699439
Blood. 2011 Mar 24;117(12):3402-8
pubmed: 21270441

Auteurs

Niquelle Brown Wadé (NB)

Department of Preventive Medicine, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Cigna Health and Life Insurance Company (Cigna), Bloomfield, CT, USA.

Cindy M Chang (CM)

Division of Population Health Sciences, Center for Tobacco Products, Food and Drug Administration, Bethesda, MD, USA.

David Conti (D)

Department of Preventive Medicine, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Joshua Millstein (J)

Department of Preventive Medicine, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Christine Skibola (C)

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.

Alexandra Nieters (A)

Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.

Sophia S Wang (SS)

Department of Computational and Quantitative Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

Silvia De Sanjose (S)

Sexual and Reproductive Health, PATH, Seattle, WA, USA.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Eleanor Kane (E)

Department of Health Sciences, University of York, York, YO10 5DD, UK.

John J Spinelli (JJ)

Population Oncology, BC Cancer Agency, Vancouver, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

Paige Bracci (P)

Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA.

Yawei Zhang (Y)

Department of Surgery, Yale School of Medicine and Yale School of Public Health, New Haven, CT, USA.

Susan Slager (S)

Department of Epidemiology, Mayo Clinic, Rochester, MN, USA.

Jun Wang (J)

Department of Preventive Medicine, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Henrik Hjalgrim (H)

Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Department of Haematology, Rigshospitalet, Copenhagen, Denmark.

Karin Ekstrom Smedby (KE)

Karolinska Institutet, Sweden University Hospital, Karolinska University, Stockholm, Sweden.

Elizabeth E Brown (EE)

Department of Pathology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

Ruth F Jarrett (RF)

MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland.

Wendy Cozen (W)

Department of Preventive Medicine, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. wcozen@med.usc.edu.
USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. wcozen@med.usc.edu.
Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA. wcozen@med.usc.edu.
ORCID: 0000-0003-3415-8247

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Théorème de Bayes › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études cas-témoins › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Phénomènes génétiques › Génotype › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Mononucléose infectieuse › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Autorapport › Infectious mononucleosis, immune genotypes,...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Infectious mononucleosis, immune genotypes,...